RESINCOLESTIRAMINA

This brand name is authorized in Hong Kong, Malta, Singapore

Active ingredients

The drug RESINCOLESTIRAMINA contains one active pharmaceutical ingredient (API):

1 Cholestyramine resin (anhydrous) UNII 4B33BGI082 - CHOLESTYRAMINE

Colestyramine resin absorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the faeces. This results in an increased faecal loss of bile acids which leads to an increased oxidation of cholesterol to bile acids and a decrease in serum cholesterol levels and low density lipoprotein serum levels. Read about Colestyramine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AC01	Colestyramine	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 65164
Country: MT	Medicines Authority	Identifier(s): AA853/00101
Country: SG	Health Sciences Authority	Identifier(s): 06583P